Overall, based on this evidence, my feeling is that 1) there is evidence of adverse effects beyond the anecdotal (Morton et al., 30% adverse effects seems highly significant), 2) there is a plausible candidate mechanism by which these adverse effects manifest (TEAS), 3) there is no discussion concerning how to alleviate these potential risks, or to select a sample with mitigated risk to develop adverse symptoms.
← all excerpts
"A sense of the bigger picture:" A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use.
1
—
—